Fulminant polyarteritis nodosa associated with acute myeloid leukaemia resulted in bilateral lower leg amputation SIR, A 42-year-old white male patient with a history of smoking was diagnosed with myelodysplastic syndrome (MDS) 10 years ago [classified as refractory anaemia with excess blasts (RAEB)], and was treated with chemotherapy [thioguanine, cytarabine, daunorubicin/high-dose cytarabine, mitoxantrone (TAD/HAM)] and considered to be in complete remission for the last 9 years.
On admission to our clinic, the patient presented with mild oedema, livedo reticularis and erythematous, partly confluent indolent papules and nodules on the frontal and lateral aspects of both lower legs. Besides that, testicular pain with changing localization, intermittent claudication and paresthesia of different areas of the right leg had occurred. Laboratory findings on admission including immunological and haematological parameters were largely normal, with the sole exception of a moderate proteinuria (350 mg/day). Blood pressure was documented within normal limits. Histological analyses of a pre-tibial skin biopsy and of testis tissue were indicative of PAN. At this time point, the patient was remitted to the Department of Urology. CT scans of the abdomen revealed bilateral segmental kidney infarctions without apparent pathologies of the large abdominal vessels.
Prior to the initiation of immunosuppressive therapy, the patient suffered from an infarction of the brain stem with rightsided hemiparesis at home, leading to admission of the patient to the Department of Internal Medicine. Due to lack of evidence of vasculitic processes in cerebral magnetic resonance angiography (MRA), the patient was started on acetylsalicylic acid. Six weeks later, the patient developed acute and severe pain of the lower extremities, sudden coldness and paresthesia of both feet. MRA disclosed acute occlusions of the right fibular artery, as well as the left anterior and posterior tibial artery ( Fig. 1a ). Sequential therapeutic interventions with high-dose corticosteroid pulses, cyclophosphamide, plasmapheresis and bosentan failed to slow progression of the disease. Eventually, complete necrosis of both feet developed over the following 5 weeks ( Fig. 1b ). Repeated MRA showed almost complete occlusion of all three major arteries in both lower legs. At this point, amputation of both lower legs was inevitable.
Eight weeks after surgery, follow-up haematological analysis showed a blast crisis. The patient was diagnosed with a reactivation of MDS with transformation into an acute myeloid leukaemia (AML) resulting in allogeneic stem cell transplantation. Another 4 weeks after this procedure, the patient suffered from a relapse of the AML and deceased shortly thereafter. This is an unusual case of fulminant PAN in a patient with a history of MDS. The triad of systemic vasculitis and orchitis, ANCA negativity and abnormal angiography in the absence of glomerulonephritis is highly suggestive of PAN [1]. Our patient met all three criteria and 6 of 10 ACR criteria [2] . Histological examination of skin and testicular biopsy specimens confirmed our diagnosis. In addition, the patient suffered from an infarction of the brain stem. However, as no signs of vasculitis were found by MRA, the patient initially received acetylsalicylic acid. This was followed later by immunosuppressive systemic therapy after involvement of the arteries of the lower legs was diagnosed. It remains speculative whether the patient would have profited from an earlier initiation of systemic therapy.
Although profound systemic inflammation is a hallmark feature of PAN, reports of prolonged ischaemia of the lower legs despite aggressive systemic therapy are rare [3, 4] . Only one report in the English literature describes leg amputation due to PAN as a last resort [5] . In our patient, we found initially no evidence of an underlying condition that contributed to the rapid progression of PAN such as thrombophilia or any other haematologic disorder.
The second remarkable aspect of this case concerns the existence of MDS in remission prior to manifestation of vasculitis symptoms and the development of AML during the course of the disease. In a prospective study in 60 MDS patients, PAN-type systemic vasculitis and PMR were proposed to be the most frequent rheumatological findings [6] . In our patient, the relationship between PAN and AML remains unclear. Given that the carcinogenicity of cyclophosphamide is considered to be dose related and usually occurs as long-term complication after years [7] , the treatment period of 4 weeks appears too short for the induction of leukaemia. Therefore, we favour the diagnosis of a vasculitis-associated malignancy in our patient. In a retrospective 10-year study of 60 patients with vasculitis-associated malignancies, 14 patients (23%) were identified with vasculitis prior to manifestation of the tumour (mean time interval: 11.9 months) [8] . The type of vasculitis in 10 of these 14 patients was described as PAN, just like in our patient (whose MDS was in remission for 9 years).
In conclusion, PAN represents an often hardly predictable and potentially fatal disease. The diagnosis of vasculitis should prompt intensive examination of other disease manifestation sites besides the skin as a prerequisite for a decision on therapy.
Rheumatology key message
Amputation of extremities may be inevitable in exceptional cases of PAN.
Disclosure statement: The authors have declared no conflicts of interest. Sarcoidosis or scleroderma? An unusual case of sarcoidosis in a 3-year-old Caucasian girl SIR, A 3-year-old girl presented with generalized pain, stiffness and tightness of skin over 4 months. She was stiff, unable to walk or open and close her hands fully, became anorexic and her growth dropped significantly. She had no difficulties with swallowing or breathing, no RP or symptoms to suggest Mycobacterium infection.
On examination, her skin was shiny and indurated. She had sclerodactyly, livedo reticularis and her range of movement was significantly reduced particularly in the MCP and IP joints of hands. Her blood pressure was at the 95th percentile. Ophthalmological examination revealed bilateral Meibomian gland dysfunction and punctate epithelial erosions. Nail-fold capillaries and other examinations were unremarkable. Table 1 shows the laboratory investigations. She was anaemic with high acute-phase reactants. Renal function was impaired (creatinine 80 mol/l) and serum calcium was grossly elevated (3.6 mmol/l) with suppressed PTH. The 1,25 dihydroxycholecalciferol was at the high end of normal. Skeletal survey showed generalized osteopenia and she was given 25-OH vitamin D supplementation before assessment. Despite ceasing the supplement and hyperhydration, the hypercalcaemia persisted.
Antibody screen found negative ANAs and ENAs (anti-Scl 70, ACAs, anti-Ro, -La and anti-RNP). RF was positive (66 IU/ml, range 0-20) and her angiotensin-converting enzyme (ACE) level was elevated at 238 U/l (0-90). Urine albumin creatinine ratio was normal.
MRI of thighs showed mildly increased signal from muscle and fascia on T2-and STIR-weighted sequences. These were consistent with myositis. Echo found no cardiac involvement or pulmonary hypertension. Chest X-ray and high-resolution CT scan showed no evidence of lymphadenopathy or parenchymal lung disease. Barium meal was normal.
Skin biopsy taken from thigh showed focally prominent perivascular collections of epithelioid cells but not fibrosis. Renal biopsy showed a multinucleated giant cell reaction in the interstitium. Both pointed to the diagnosis of sarcoidosis. No granuloma was demonstrated histologically. There was no clinical or histological evidence of mycobacterium infection. Bone marrow examination was negative.
A diagnosis of sarcoidosis alone or overlap with dcSSc was made. Due to the hypercalcaemia and severe skin disease, she was treated with pulsed intravenous methylprednisolone, followed by reducing doses of oral prednisolone. Serum calcium and renal function normalized and her skin became less inflamed allowing improved mobility. Meibomian gland dysfunction also resolved. She commenced subcutaneous MTX 15 mg/m 2 as maintenance. She remained well with no recurrence of symptoms at follow-up 5 months later.
Sarcoidosis can co-exist with various CTDs including SSc in adults [1] [2] [3] [4] . Enzenauer and West [2] reported that 6 out of 569 adult patients with CTDs developed sarcoidosis over 10 years. Sarcoidosis was usually diagnosed due to the presence of hilar lymphadenopathy, systemic or respiratory symptoms and proven on biopsy. Renal failure due to sarcoidosis on first presentation was also rare [5] .
Hypercalcaemia is reported in $10% of the adult patients with sarcoidosis [5] and as high as 30% in children [6] . The mechanism is thought to be an increased 1-hydroxylase activity of macrophages in granuloma, especially in patients with pulmonary involvement. However, it was also demonstrated in those without lung granuloma [7] . A normal 1,25 dihydroxyvitamin D does not exclude sarcoidosis as the cause of hypercalcaemia [8] . Furthermore, Bell et al.
[9] demonstrated that addition of small amount of vitamin D caused hypercalcaemia in sarcoidosis patients but not in normal subjects.
In our case, sarcoidosis was diagnosed based on histology, hypercalcaemia and persistently elevated ACE, though pulmonary disease and lymphadenopathy were absent and skin involvement was clinically atypical for sarcoidosis.
It is possible to speculate that this case represents sarcoidosis mimicking SSc rather than an overlap. However, the current classification for childhood SSc does not require exclusion of sarcoidosis [10]. While we cannot be certain that the muscle and eye involvement seen in this case was due to sarcoidosis as we have no histological specimens, sarcoidosis could definitely be the cause of the inflammatory myositis in this case. In fact, sarcoidosis can 
